| Year |
Citation |
Score |
| 2020 |
Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, ... ... Gallie BL, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. Jama Oncology. PMID 32105305 DOI: 10.1001/Jamaoncol.2019.6716 |
0.544 |
|
| 2020 |
Soliman SE, VandenHooven C, MacKeen L, Gallie B. Abstract A68: Optical coherence tomography improves subclinical retinoblastoma management Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-A68 |
0.304 |
|
| 2018 |
AlAli A, Kletke S, Gallie B, Lam WC. Retinoblastoma for Pediatric Ophthalmologists. Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.). PMID 29737052 DOI: 10.22608/Apo.201870 |
0.335 |
|
| 2016 |
Racher H, Soliman S, Argiropoulos B, Chan HS, Gallie BL, Perrier R, Matevski D, Rushlow D, Piovesan B, Shaikh F, MacDonald H, Corson TW. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma. Cancer Genetics. PMID 27318443 DOI: 10.1016/J.Cancergen.2016.06.001 |
0.608 |
|
| 2015 |
Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, Gallie BL. Retinoblastoma. Nature Reviews. Disease Primers. 1: 15021. PMID 27189421 DOI: 10.1038/nrdp.2015.21 |
0.616 |
|
| 2015 |
Corson T, Racher H, Argiropoulos B, Chan H, Perrier R, Matevski D, Rushlow D, Shaikh F, Trang H, Gallie B. MG-127 Residual disease monitoring in a retinoblastoma patient by pcr of a novel deletion breakpoint Journal of Medical Genetics. 52: A10.2-A10. DOI: 10.1136/Jmedgenet-2015-103578.27 |
0.624 |
|
| 2014 |
Thériault BL, Basavarajappa HD, Lim H, Pajovic S, Gallie BL, Corson TW. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer. Plos One. 9: e91540. PMID 24626475 DOI: 10.1371/Journal.Pone.0091540 |
0.753 |
|
| 2014 |
Thériault BL, Dimaras H, Gallie BL, Corson TW. The genomic landscape of retinoblastoma: a review. Clinical & Experimental Ophthalmology. 42: 33-52. PMID 24433356 DOI: 10.1111/Ceo.12132 |
0.587 |
|
| 2014 |
Milea A, George SH, Matevski D, Jiang H, Madunic M, Berman HK, Gauthier ML, Gallie B, Shaw PA. Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 991-1001. PMID 24336157 DOI: 10.1038/Modpathol.2013.218 |
0.347 |
|
| 2013 |
Rushlow DE, Mol BM, Kennett JY, Yee S, Pajovic S, Thériault BL, Prigoda-Lee NL, Spencer C, Dimaras H, Corson TW, Pang R, Massey C, Godbout R, Jiang Z, Zacksenhaus E, ... ... Gallie BL, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. The Lancet. Oncology. 14: 327-34. PMID 23498719 DOI: 10.1016/S1470-2045(13)70045-7 |
0.604 |
|
| 2012 |
Corson TW, Pajovic S, Dimaras H, Thériault BL, Gallie BL. Author response: Does the time of inactivation of pRb determine the cell of origin of retinoblastoma? Investigative Ophthalmology & Visual Science. 53: 676. PMID 22331504 DOI: 10.1167/Iovs.11-9371 |
0.548 |
|
| 2012 |
Thériault BL, Pajovic S, Bernardini MQ, Shaw PA, Gallie BL. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 130: 1844-54. PMID 21618518 DOI: 10.1002/Ijc.26189 |
0.311 |
|
| 2012 |
Kurban G, Tsavachidou D, Gallie B, Evans A, Finelli A, Jonasch E, Jewett M. Abstract 1278: Determining the proteomic changes that define progressor and non-progressor clear cell renal cell carcinoma Cancer Research. 72: 1278-1278. DOI: 10.1158/1538-7445.Am2012-1278 |
0.331 |
|
| 2011 |
Pajovic S, Corson TW, Spencer C, Dimaras H, Orlic-Milacic M, Marchong MN, To KH, Thériault B, Auspitz M, Gallie BL. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. Investigative Ophthalmology & Visual Science. 52: 7618-24. PMID 21862643 DOI: 10.1167/Iovs.11-7989 |
0.599 |
|
| 2011 |
Lohmann D, Gallie B, Dommering C, Gauthier-Villars M. Clinical utility gene card for: retinoblastoma. European Journal of Human Genetics : Ejhg. 19. PMID 21150892 DOI: 10.1038/Ejhg.2010.200 |
0.317 |
|
| 2008 |
Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC, Squire JA, Gallie BL. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Human Molecular Genetics. 17: 1363-72. PMID 18211953 DOI: 10.1093/Hmg/Ddn024 |
0.641 |
|
| 2007 |
Paderova J, Orlic-Milacic M, Yoshimoto M, da Cunha Santos G, Gallie B, Squire JA. Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses. Cancer Genetics and Cytogenetics. 179: 102-11. PMID 18036396 DOI: 10.1016/J.Cancergencyto.2007.08.014 |
0.326 |
|
| 2007 |
Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, Hughes TR, Blencowe BJ, Frey BJ, Morris QD. Using expression profiling data to identify human microRNA targets. Nature Methods. 4: 1045-9. PMID 18026111 DOI: 10.1038/Nmeth1130 |
0.554 |
|
| 2007 |
Madhavan J, Coral K, Mallikarjuna K, Corson TW, Amit N, Khetan V, George R, Biswas J, Gallie BL, Kumaramanickavel G. High expression of KIF14 in retinoblastoma: association with older age at diagnosis. Investigative Ophthalmology & Visual Science. 48: 4901-6. PMID 17962437 DOI: 10.1167/Iovs.07-0063 |
0.622 |
|
| 2007 |
Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3229-34. PMID 17545527 DOI: 10.1158/1078-0432.Ccr-07-0393 |
0.556 |
|
| 2007 |
Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes, Chromosomes & Cancer. 46: 617-34. PMID 17437278 DOI: 10.1002/Gcc.20457 |
0.633 |
|
| 2007 |
Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PB, Gallie BL. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes, Chromosomes & Cancer. 46: 118-29. PMID 17099872 DOI: 10.1002/Gcc.20383 |
0.628 |
|
| 2006 |
Corson TW, Gallie BL. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer. International Journal of Cancer. 119: 1088-94. PMID 16570270 DOI: 10.1002/Ijc.21954 |
0.606 |
|
| 2006 |
Orlic M, Spencer CE, Wang L, Gallie BL. Expression analysis of 6p22 genomic gain in retinoblastoma Genes Chromosomes and Cancer. 45: 72-82. PMID 16180235 DOI: 10.1002/gcc.20263 |
0.323 |
|
| 2006 |
Albrecht P, Ansperger-Rescher B, Schüler A, Zeschnigk M, Gallie B, Lohmann DR. Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression. Human Mutation. 26: 437-45. PMID 16127685 DOI: 10.1002/Humu.20234 |
0.334 |
|
| 2005 |
Spencer C, Pajovic S, Devlin H, Dinh QD, Corson TW, Gallie BL. Distinct patterns of expression of the RB gene family in mouse and human retina. Gene Expression Patterns : Gep. 5: 687-94. PMID 15939381 DOI: 10.1016/J.Modgep.2005.02.003 |
0.621 |
|
| 2005 |
Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene. 24: 4741-53. PMID 15897902 DOI: 10.1038/Sj.Onc.1208641 |
0.626 |
|
| 2004 |
Marchong MN, Chen D, Corson TW, Lee C, Harmandayan M, Bowles E, Chen N, Gallie BL. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Molecular Cancer Research : McR. 2: 495-503. PMID 15383628 |
0.631 |
|
| 2004 |
DiCiommo DP, Duckett A, Burcescu I, Bremner R, Gallie BL. Retinoblastoma protein purification and transduction of retina and retinoblastoma cells using improved alphavirus vectors. Investigative Ophthalmology & Visual Science. 45: 3320-9. PMID 15326157 DOI: 10.1167/Iovs.04-0140 |
0.713 |
|
| 2003 |
Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. American Journal of Human Genetics. 72: 253-69. PMID 12541220 DOI: 10.1086/345651 |
0.303 |
|
| 2002 |
Chen D, Pajovic S, Duckett A, Brown VD, Squire JA, Gallie BL. Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN Cancer Research. 62: 967-971. PMID 11861365 |
0.747 |
|
| 2002 |
Brown VD, Gallie BL. The B-domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylation. Molecular and Cellular Biology. 22: 1390-401. PMID 11839806 DOI: 10.1128/Mcb.22.5.1390-1401.2002 |
0.722 |
|
| 2001 |
Chen D, Squire J, Gallie B. Genomic amplification in retinoblastoma narrowed to 1.2 Mb on chromosome 6p containing a novel kinesin-like gene, RBKIN Nature Genetics. 27: 46-46. DOI: 10.1038/87028 |
0.348 |
|
| 1999 |
Brown VD, Phillips RA, Gallie BL. Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Molecular and Cellular Biology. 19: 3246-56. PMID 10207050 DOI: 10.1128/Mcb.19.5.3246 |
0.728 |
|
| 1997 |
Cohen B, Bashirullah A, Dagnino L, Campbell C, Fisher WW, Leow CC, Whiting E, Ryan D, Zinyk D, Boulianne G, Hui CC, Gallie B, Phillips RA, Lipshitz HD, Egan SE. Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila. Nature Genetics. 16: 283-8. PMID 9207795 DOI: 10.1038/Ng0797-283 |
0.328 |
|
| 1992 |
Lothe RA, Fossli T, Danielsen HE, Stenwig AE, Nesland JM, Gallie B, Børresen AL. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors. Journal of the National Cancer Institute. 84: 1100-8. PMID 1619684 DOI: 10.1093/Jnci/84.14.1100 |
0.364 |
|
| 1992 |
Lothe R, Fossli T, Danielsen H, Stenwig A, Nesland J, Gallie B, Børresen A. Colorectal tumours examined for genetic changes at chromosomes 13 and 17 with special reference to the RB1 and TP53 genes Cancer Genetics and Cytogenetics. 63: 123. DOI: 10.1016/0165-4608(92)90427-A |
0.312 |
|
| Show low-probability matches. |